Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q3 · 1,5 6 matched articles ESCI

Journal detail

Journal of Scleroderma and Related Disorders

Publisher
SAGE Publications Ltd
Country
Italy · Western Europe
Type
journal
ISSN
  • 23971983
  • 23971991
Scopus 0,631 SJR
Scopus Q2 SJR Q
WoS Q3 JCR Q
WoS 1,5 JIF
Scopus 30 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,631
  • Quartile Q2
  • H-Index 30
  • Cites/doc 1,38
  • Docs (3y) 101
  • Cites (3y) 186

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 1,5
  • 5Y JIF 2,1
  • JCI 0,3

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Immunology Q3
  • Immunology and Allergy Q3
  • Rheumatology Q2

Areas

  • Immunology and Microbiology
  • Medicine

WoS categories

  • Rheumatology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q3 0,631 1,5 2,1 0,3 Q4 30
2024 Q3 Q4 0,6 1,2 2 0,31 Q4 27
2023 Q2 Q3 0,766 1,4 2 0,36 Q3 27
2022 Q3 — 0,545 2 2,5 0,41 Q3 27
2021 Q3 — 0,528 — — 0,45 Q3 27
2020 Q1 — 1,738 — — 0,48 Q3 27
2019 Q1 — 1,968 — — — — 27
2017 — — — — — — — 27
2016 — — — — — — — 27

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 RHEUMATOLOGY ESCI Q3 Q4 41/58
2024 RHEUMATOLOGY ESCI Q4 Q4 48/58
2023 RHEUMATOLOGY ESCI Q3 Q3 40/57
2022 RHEUMATOLOGY ESCI — Q3 —
2021 RHEUMATOLOGY ESCI — Q3 —
2020 RHEUMATOLOGY ESCI — Q3 —